Article Text

AB0216 Effects of anti-citrullinated protein antibodies on systemic bone mass in rheumatoid arthritis patients
  1. G Orsolini,
  2. C Caimmi,
  3. O Viapiana,
  4. L Idolazzi,
  5. E Fracassi,
  6. D Gatti,
  7. G Adami,
  8. M Rossini
  1. Rheumatology Unit, University of Verona, Verona, Italy


Background Bone loss in rheumatoid arthritis (RA) is a key feature both local and systemic. Anti-citrullinated protein antibodies (ACPA) have recently been found to directly induce differentiation and activation of osteoclasts and therefore contribute to periarticular bone loss.

Objectives The aim of this study was to analyze the effect of ACPA on systemic bone mineral density (BMD) in patients with established RA.

Methods This is a cross-sectional study with a single-center RA population. BMD was measured with Dual X-ray absorptiometry at lumbar and femoral sites. ACPA were measured by EIA. Multivariate analysis was performed adjusting for the main confounding variables.

Results One hundred twenty-seven RA patients were enrolled. In univariate analysis ACPA-positive patients showed lower BMD Z-score (SD below the age- and gendermatched mean reference value) at femoral sites (p<0.01). A negative correlation between ACPA titer and BMD Z-score at all sites was observed (p<0.01). The multivariate analysis adjusted for the main confounding variables confirmed the negative effect of ACPA at femoral sites (p<0.05), but not at lumbar spine BMD. No significant effect of rheumatoid factor has been observed.

Conclusions ACPA have a negative titer-dependent effect on BMD at femoral sites, mainly constituted by cortical bone. ACPA-positive patients, especially if at high titer, should undergo bone investigations and be treated with bone protecting agents. Disease-modifying anti-rheumatic drugs lowering ACPA titer might have positive effects on systemic bone mass.

Disclosure of Interest None declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.